# Cellulitis

Manage presumed cellulitis by first excluding a drainable abscess and necrotizing infection, then matching antibiotics to purulence, systemic severity, and MRSA risk. Most uncomplicated nonpurulent cases require streptococcal coverage, source-control assessment, and reassessment within 48 hours.

**Clinical question:** How should physicians distinguish cellulitis from abscess or necrotizing infection and choose empiric treatment and disposition?

Updated: 2026-08-21T02:18:53.840356+00:00

## What matters in practice
- A fluctuant or purulent lesion is not uncomplicated cellulitis: identify and drain a purulent collection, with antibiotics used selectively according to systemic illness and host factors. [12][13]
- Treat typical nonpurulent cellulitis without systemic signs with an agent active against streptococci rather than routine MRSA-directed therapy. [10][23]
- Use ultrasound when examination cannot confidently exclude an occult superficial abscess; it can differentiate cellulitis from fluid collection and guide incision and drainage. [8][17][23]
- Escalate immediately for suspected necrotizing soft-tissue infection; it can mimic cellulitis or abscess, and delayed recognition is consequential. [1][9]
- Do not routinely obtain blood cultures or imaging in uncomplicated presumed cellulitis; use targeted testing when an alternative diagnosis, abscess, deep extension, or systemic illness is suspected. [2][22]

## Classify the lesion before selecting antibiotics

The first management decision is whether inflammation overlies pus or represents diffuse nonpurulent infection.

Call the process nonpurulent cellulitis only when there is diffuse spreading inflammation without purulent drainage, exudate, or an associated abscess. A furuncle, septic bursa, or skin abscess with surrounding erythema requires source control of the suppurative focus rather than treatment as uncomplicated cellulitis. [8][12]

Look specifically for fluctuance, spontaneous purulent drainage, focal pointing, or a palpable fluid-filled cavity. When findings are equivocal, perform point-of-care ultrasound: superficial abscess is best assessed with ultrasound, and dynamic compression plus color Doppler can help define a drainable collection and surrounding hyperemia. [15][17][23]

Do not allow an apparently uncomplicated presentation to delay escalation when pain, toxicity, progression, or examination raises concern for deep infection. Necrotizing soft-tissue infections commonly mimic cellulitis or abscess; obtain urgent surgical assessment rather than relying on imaging to exclude a clinically suspected necrotizing process. [1][9]
- Purulent collection: perform incision and drainage; a dry dressing is generally preferred after drainage, whereas routine gauze packing increases pain without demonstrated healing benefit in the cited small study. [13]
- Nonpurulent diffuse infection: proceed with streptococcal-directed antimicrobial selection and outpatient-versus-inpatient assessment. [10][23]
- Uncertain anatomy or suspected deep complication: use ultrasound for superficial abscess and CT when defining deeper extension or the involved anatomic compartment will change management. [17][22]

*Lesion phenotype directs source control and empiric antimicrobial spectrum. [10][12][13][23]*

| Clinical pattern | Key discriminator | Immediate action | Antimicrobial implication |
| --- | --- | --- | --- |
| Typical nonpurulent cellulitis | No drainage, exudate, or associated abscess [8][12] | Assess systemic illness and treat medically [10] | Use streptococcal-active therapy; routine MRSA coverage is not required in typical mild disease. [10][23] |
| Abscess or other purulent SSTI | Fluctuance, drainage, or fluid collection on ultrasound [15][17][23] | Incision and drainage is the primary intervention. [12][13] | Consider MRSA-active therapy when systemic signs or higher-risk features are present. [13][15] |
| Possible necrotizing soft-tissue infection | Clinical concern despite cellulitis-like or abscess-like appearance [1][9] | Urgent surgical evaluation [1][9] | Do not manage as routine outpatient cellulitis. [1][9] |

## Use systemic severity and host factors to determine workup and site of care

Testing should answer a specific question: bacteremia, occult pus, deep extension, or an alternative diagnosis.

For presumed uncomplicated cellulitis, routine blood cultures and routine imaging have limited clinical usefulness; reserve them for patients with systemic illness, atypical findings, failure of initial management, or concern for a deeper process. CT is useful when deep complications or the involved anatomic compartment must be identified. [2][22]

Systemic signs that support escalation in purulent SSTI include temperature greater than 38°C or less than 36°C, tachycardia, tachypnea, white blood cell count greater than 12,000/µL, or white blood cell count less than 400/µL. These findings support culture of purulent material and empiric systemic anti-staphylococcal treatment in addition to drainage. [13]

Consider hospital-based management for patients who are severely unwell, frail, immunocompromised, elderly, very young, or who have facial cellulitis. Patients who can take oral therapy and lack these high-risk features can usually be managed as outpatients with explicit reassessment instructions. [16][19][23]

At follow-up, judge response clinically rather than by a microbiologic endpoint, because pathogen recovery in nonpurulent cellulitis is uncommon, with a reported clinical isolation rate below 20%. Worsening or no improvement by 48 hours should trigger re-examination for occult abscess, an incorrect diagnosis, resistant pathogen, nonadherence, or deep infection. [12][15]
- Obtain ultrasound when a missed abscess would change management. [8][17][23]
- Culture drained purulent material when systemic signs are present or initial treatment fails. [13][15]
- Use CT for suspected deep extension rather than as routine imaging for superficial uncomplicated cellulitis. [2][22]
- Provide a 48-hour follow-up plan, particularly when MRSA is possible or clinical improvement is uncertain. [15]

## Match antibiotics to purulence, MRSA risk, and ability to take oral therapy

Antibiotics do not substitute for drainage when a collection is present.

For mild nonpurulent cellulitis, select an oral agent active against streptococci. Recommended options include penicillin V potassium, a cephalosporin, dicloxacillin, or clindamycin; penicillin, amoxicillin, and cephalexin are cited oral options for targeted streptococcal coverage. [10][21][23]

For purulent infection or an abscess requiring adjunctive antibiotics, choose MRSA-active therapy such as trimethoprim-sulfamethoxazole, doxycycline, or clindamycin. CDC advises considering MRSA particularly for purulent, fluctuant, or fluid-filled skin infections. [4][6][15][23]

Use clindamycin when it is selected at 300 to 450 mg orally three or four times daily; use trimethoprim-sulfamethoxazole at one to two double-strength tablets orally twice daily. In hospitalized cellulitis cohorts, inadequate dosing of clindamycin or trimethoprim-sulfamethoxazole was independently associated with clinical failure; obesity may require attention to dose adequacy. [4][6]

Do not add trimethoprim-sulfamethoxazole routinely to cephalexin for uncomplicated nonpurulent cellulitis solely to broaden MRSA coverage. Typical nonpurulent cellulitis is usually due to beta-hemolytic streptococci, while MRSA accounts for a small proportion of nonpurulent cases in the cited emergency medicine review. [3][10][23]

Avoid a single empiric vancomycin dose before discharge for a hemodynamically stable patient with nonpurulent cellulitis. Vancomycin trough targets of 10 to 15 µg/mL are achieved after four to five doses, making one emergency department dose unlikely to have meaningful clinical effect while adding unnecessary broad-spectrum exposure and monitoring burden. [5]
- Nonpurulent, no systemic signs: use a streptococcal-active oral regimen. [10][21][23]
- Purulence or drained abscess with systemic signs: add systemic anti-staphylococcal therapy with MRSA activity. [13][15][23]
- Penetrating trauma, MRSA infection or colonization elsewhere, injection drug use, or SIRS: cover both MRSA and streptococci. [13]
- Typical treatment duration is 5 to 10 days; immunocompromised patients may require 7 to 14 days. [23]

*Empiric outpatient treatment choices by cellulitis phenotype. [4][6][10][13][21][23]*

| Presentation | Preferred management | Oral options supported in cited guidance | Key limitation |
| --- | --- | --- | --- |
| Mild nonpurulent cellulitis | Streptococcal-active antibiotic [10][23] | Penicillin V potassium, amoxicillin, cephalexin, dicloxacillin, or clindamycin [21][23] | Do not treat an unrecognized abscess with antibiotics alone. [12][23] |
| Purulent SSTI after drainage when antibiotics are indicated | MRSA-active systemic therapy plus source control [13][15] | TMP-SMX 1–2 double-strength tablets twice daily; doxycycline; or clindamycin 300–450 mg three or four times daily [4][6][23] | Culture and susceptibility testing should guide treatment for severe or nonresponding infection. [15] |
| Nonpurulent cellulitis with MRSA-risk features | Cover MRSA and streptococci [13] | Clindamycin is listed among oral options; select therapy according to syndrome and susceptibility data when available. [4][6][13] | Resistance to clindamycin, tetracycline, and TMP-SMX has been reported among S. aureus; resistance to erythromycin and clindamycin has also been reported among streptococci. [12][14] |

## Drain abscesses and escalate immediately when cellulitis is not the right diagnosis

Failure after appropriate oral therapy should prompt a new anatomic and diagnostic assessment.

For a mild purulent SSTI, incision and drainage alone is often sufficient. Add culture and empiric systemic anti-staphylococcal antibiotics when the patient has fever above 38°C or below 36°C, tachycardia, tachypnea, or marked leukocyte abnormality. [13]

When no clinical improvement occurs after initial therapy, repeat examination and use ultrasound to look for a previously occult collection. The clinical importance of this step is underscored by trials of nonpurulent cellulitis in which some apparent treatment failures may have represented small abscesses missed despite ultrasound screening. [3][8]

Escalate to emergency surgical evaluation when the course is disproportionate to apparent superficial infection or when necrotizing soft-tissue infection remains plausible. NSTI may present as an apparently benign cellulitis or abscess, so a reassuring initial label should not override progressive clinical concern. [1][9]
- Drainage first for abscess; do not call erythema surrounding an infected bursa or furuncle uncomplicated cellulitis. [12]
- Use a simple dry dressing after drainage rather than routine packing when appropriate. [13]
- Obtain CT if defining deep extension or anatomic compartment will change procedural planning. [22]

## Reassess at 48 hours and address recurrent lower-extremity risk factors

Recurrence prevention begins with finding the skin barrier or lymphatic vulnerability driving repeated episodes.

Document the lesion boundary at the initial visit and reassess symptoms, systemic signs, and spread within 48 hours. Lack of improvement should trigger reassessment for abscess, deeper infection, or a different diagnosis rather than automatic prolongation or broadening of therapy. [15][22][23]

For recurrent lower-extremity cellulitis, examine interdigital spaces and nails for tinea pedis or onychomycosis and address chronic edema, obesity, and lymphatic dysfunction when present. Athlete's foot has been associated with lower-extremity cellulitis, and obesity can impair lymphatic fluid transport. [18]

In patients with severe infection that fails initial treatment, obtain culture and susceptibility testing when a recoverable purulent focus is present and use results to direct therapy. This is increasingly relevant because resistance among S. aureus to methicillin, erythromycin, clindamycin, tetracycline, and TMP-SMX, and among streptococci to erythromycin and clindamycin, has been reported. [12][14][15]
- Re-examine within 48 hours if outpatient improvement is uncertain or symptoms worsen. [15]
- For recurrence, inspect for interdigital fungal disease and contributors to impaired lymphatic drainage. [18]
- For severe or nonresponding purulent disease, use susceptibility results to narrow or change therapy. [15]

## References
1. Necrotizing Soft Tissue Infection Masquerading as ... — jamanetwork.com — https://jamanetwork.com/journals/jamasurgery/fullarticle/211678
2. Clinical Usefulness of Imaging and Blood Cultures ... — jamanetwork.com — https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2676998
3. Effect of Cephalexin Plus Trimethoprim-Sulfamethoxazole ... — jamanetwork.com — https://jamanetwork.com/journals/jama/fullarticle/2627970
4. Clinical outcomes in patients hospitalized with cellulitis treated with oral clindamycin and trimethoprim/sulfamethoxazole: The role of weight-based dosing — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S0163445317302980
5. Reduction of Inappropriate Antibiotic Use and Improved Outcomes by Implementation of an Algorithm-Based Clinical Guideline for Nonpurulent Skin and Soft Tissue Infections — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S0196064419314532
6. Clinical outcomes in patients hospitalized with cellulitis treated with oral clindamycin and trimethoprim/sulfamethoxazole: The role of weight-based dosing - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S0163445317302980
7. Current and future trends in antibiotic therapy of acute ... — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S1198743X16300957/pdf?md5=
8. Clinical Practice Guidelines by the Infectious Diseases Society ... — academic.oup.com — https://academic.oup.com/cid/article/52/3/e18/306145
9. Diagnostic strategies in necrotizing soft tissue infections: from ... — academic.oup.com — https://academic.oup.com/burnstrauma/article/doi/10.1093/burnst/tkag028/8653883
10. 2014 Update by the Infectious Diseases Society of America — academic.oup.com — https://academic.oup.com/cid/article/59/2/e10/2895845
11. Diagnosis and Treatment of Diabetic Foot Infections — academic.oup.com — https://academic.oup.com/cid/article/39/7/885/493357
12. IDSA 2014 Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections — idsociety.org — https://idsociety.org/practice-guideline/skin-and-soft-tissue-infections
13. Clinical Practice Guidelines for Skin and Soft Tissue Infections | AAP Grand Rounds | American Academy of Pediatrics — publications.aap.org — https://publications.aap.org/aapgrandrounds/article/33/2/24/90901/Clinical-Practice-Guidelines-for-Skin-and-Soft
14. Skin and Soft Tissue Infections — www.idsociety.org — https://www.idsociety.org/practice-guideline/skin-and-soft-tissue-infections
15. Clinical Overview of Methicillin-resistant Staphylococcus ... — www.cdc.gov — https://www.cdc.gov/mrsa/hcp/clinical-overview/index.html
16. Cellulitis - acute | Health topics A to Z - CKS - NICE — cks.nice.org.uk — https://cks.nice.org.uk/topics/cellulitis-acute
17. Musculoskeletal Infections: US Manifestations — pubs.rsna.org — https://pubs.rsna.org/doi/abs/10.1148/radiographics.19.6.g99no061585
18. Recurrent Cellulitis: Who is at Risk and How Effective is Antibiotic P | IJGM | Dove Medical Press — www.ccjm.org — https://www.ccjm.org/lookup/external-ref?access_num=10.2147%2FIJGM.S326459&link_type=DOI
19. Scenario: Management of acute cellulitis - CKS - NICE — cks.nice.org.uk — https://cks.nice.org.uk/topics/cellulitis-acute/management/management
20. Development and Validation of a Cellulitis Risk Score — pediatrics.aappublications.org — https://pediatrics.aappublications.org/content/143/2/e20181420
21. Cellulitis: A Review of Current Practice Guidelines and ... — www.ccjm.org — https://www.ccjm.org/lookup/external-ref?access_num=34902109&link_type=MED&atom=%2Fccjom%2F93%2F6%2F313.atom
22. Musculoskeletal Infection: Role of CT in the Emergency ... — pubs.rsna.org — https://pubs.rsna.org/doi/abs/10.1148/rg.276075033
23. THE 2024 LLSA LITERATURE REVIEW — www.acep.org — https://www.acep.org/siteassets/sites/acep/media/moc/moc-documents/cdem-2024-llsa-literature-review.pdf
24. Blood Cultures in the Evaluation of Uncomplicated Skin ... — pediatrics.aappublications.org — https://pediatrics.aappublications.org/content/132/3/454

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.